{"rows":[{"id":2729,"title":"Patterns of recreational drug use at dance events in Edinburgh, Scotland.","authors":"Riley SC, James C, Gregory D, Dingle H, Cadger M","journal":"Addiction (Abingdon, England)","publication_date":"2001-07-01","publication_year":2001,"doi":"10.1046/j.1360-0443.2001.967103513.x","pubmed_id":"11440614","openalex_id":"https://openalex.org/W2151598790","source_url":"https://pubmed.ncbi.nlm.nih.gov/11440614/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:30","bibtex":null,"source_record_id":"PMID:11440614","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/11440614/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:11440614","source_url":"https://pubmed.ncbi.nlm.nih.gov/11440614/","doi":"10.1046/j.1360-0443.2001.967103513.x","pmid":"11440614","publication_date":"2001-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2696,"title":"Response consistency in young adolescents' drug use self-reports: a recanting rate analysis.","authors":"Percy A, McAlister S, Higgins K, McCrystal P, Thornton M","journal":"Addiction (Abingdon, England)","publication_date":"2005-01-31","publication_year":2005,"doi":"10.1111/j.1360-0443.2004.00943.x","pubmed_id":"15679748","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/15679748/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Adolescents","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-07-01 06:54:14","bibtex":null,"source_record_id":"PMID:15679748","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/15679748/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:15679748","source_url":"https://pubmed.ncbi.nlm.nih.gov/15679748/","doi":"10.1111/j.1360-0443.2004.00943.x","pmid":"15679748","publication_date":"2005-01-31","importer_version":"2.1.3","text_redistributed":false}},{"id":1329,"title":"Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.","authors":"Keyes KM, Patrick ME","journal":"Addiction (Abingdon, England)","publication_date":"2023-12-01","publication_year":2023,"doi":"10.1111/add.16259","pubmed_id":"37287110","openalex_id":"https://openalex.org/W4379769663","source_url":"https://pubmed.ncbi.nlm.nih.gov/37287110/","substance_tags":"psilocybin","topic_tags":"Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:37287110","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37287110/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37287110","source_url":"https://pubmed.ncbi.nlm.nih.gov/37287110/","doi":"10.1111/add.16259","pmid":"37287110","publication_date":"2023-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1039,"title":"A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia.","authors":"Darke S, Duflou J, Peacock A, Farrell M, Hall W, Lappin J","journal":"Addiction (Abingdon, England)","publication_date":"2024-09-01","publication_year":2024,"doi":"10.1111/add.16518","pubmed_id":"38771189","openalex_id":"https://openalex.org/W4398156492","source_url":"https://pubmed.ncbi.nlm.nih.gov/38771189/","substance_tags":"psilocybin,psilocin","topic_tags":"Toxicity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:07","bibtex":null,"source_record_id":"PMID:38771189","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38771189/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38771189","source_url":"https://pubmed.ncbi.nlm.nih.gov/38771189/","doi":"10.1111/add.16518","pmid":"38771189","publication_date":"2024-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1037,"title":"Commentary on Darke et al.: Expanded psychedelic access requires new safety monitoring systems.","authors":"Korthuis PT, Wilson-Poe AR, Black JC, Monte A","journal":"Addiction (Abingdon, England)","publication_date":"2024-09-01","publication_year":2024,"doi":"10.1111/add.16589","pubmed_id":"38881433","openalex_id":"https://openalex.org/W4399750332","source_url":"https://pubmed.ncbi.nlm.nih.gov/38881433/","substance_tags":"psilocybin","topic_tags":"Safety,Toxicity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:07","bibtex":null,"source_record_id":"PMID:38881433","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38881433/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38881433","source_url":"https://pubmed.ncbi.nlm.nih.gov/38881433/","doi":"10.1111/add.16589","pmid":"38881433","publication_date":"2024-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":856,"title":"Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.","authors":"Krawczyk N, Miller M, Gu EY, Irvine N, Ramirez E, Santaella-Tenorio J, Lippincott T, Bogenschutz M, Bunting AM, Meacham MC","journal":"Addiction (Abingdon, England)","publication_date":"2025-01-16","publication_year":2025,"doi":"10.1111/add.16767","pubmed_id":"39821493","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39821493/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing,Safety","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39821493","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39821493/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39821493","source_url":"https://pubmed.ncbi.nlm.nih.gov/39821493/","doi":"10.1111/add.16767","pmid":"39821493","publication_date":"2025-01-16","importer_version":"2.1.3","text_redistributed":false}},{"id":846,"title":"Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.","authors":"Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J","journal":"Addiction (Abingdon, England)","publication_date":"2025-01-30","publication_year":2025,"doi":"10.1111/add.16762","pubmed_id":"39887551","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39887551/","substance_tags":"psilocybin","topic_tags":"Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39887551","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39887551/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39887551","source_url":"https://pubmed.ncbi.nlm.nih.gov/39887551/","doi":"10.1111/add.16762","pmid":"39887551","publication_date":"2025-01-30","importer_version":"2.1.3","text_redistributed":false}},{"id":843,"title":"Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?","authors":"Andrews CM, Hall W, Humphreys K, Marsden J","journal":"Addiction (Abingdon, England)","publication_date":"2025-02-01","publication_year":2025,"doi":"10.1111/add.16575","pubmed_id":"38845381","openalex_id":"https://openalex.org/W4399441804","source_url":"https://pubmed.ncbi.nlm.nih.gov/38845381/","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:38845381","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38845381/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38845381","source_url":"https://pubmed.ncbi.nlm.nih.gov/38845381/","doi":"10.1111/add.16575","pmid":"38845381","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":842,"title":"A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs.","authors":"Bogenschutz MP","journal":"Addiction (Abingdon, England)","publication_date":"2025-02-01","publication_year":2025,"doi":"10.1111/add.16647","pubmed_id":"39129581","openalex_id":"https://openalex.org/W4401521492","source_url":"https://pubmed.ncbi.nlm.nih.gov/39129581/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39129581","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39129581/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39129581","source_url":"https://pubmed.ncbi.nlm.nih.gov/39129581/","doi":"10.1111/add.16647","pmid":"39129581","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":841,"title":"How psychedelics legalization debates could differ from cannabis.","authors":"Kilmer B","journal":"Addiction (Abingdon, England)","publication_date":"2025-02-01","publication_year":2025,"doi":"10.1111/add.16644","pubmed_id":"39138955","openalex_id":"https://openalex.org/W4401587111","source_url":"https://pubmed.ncbi.nlm.nih.gov/39138955/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:03","bibtex":null,"source_record_id":"PMID:39138955","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39138955/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39138955","source_url":"https://pubmed.ncbi.nlm.nih.gov/39138955/","doi":"10.1111/add.16644","pmid":"39138955","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}},{"id":602,"title":"Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.","authors":"Luquiens A, Belahda D, Graux C, Igounenc N, Serrand C, Rochefort P, Mura T, Sergent F","journal":"Addiction (Abingdon, England)","publication_date":"2025-07-24","publication_year":2025,"doi":"10.1111/add.70152","pubmed_id":"40702912","openalex_id":"https://openalex.org/W4412642858","source_url":"https://pubmed.ncbi.nlm.nih.gov/40702912/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40702912","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40702912/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40702912","source_url":"https://pubmed.ncbi.nlm.nih.gov/40702912/","doi":"10.1111/add.70152","pmid":"40702912","publication_date":"2025-07-24","importer_version":"2.1.3","text_redistributed":false}},{"id":509,"title":"Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.","authors":"Knock E, Siefried KJ, Bedi G, Albert S, Day RO, Ezard N, Ross M, Liknaitzky P, Brett J","journal":"Addiction (Abingdon, England)","publication_date":"2025-09-20","publication_year":2025,"doi":"10.1111/add.70187","pubmed_id":"40974259","openalex_id":"https://openalex.org/W4414374510","source_url":"https://pubmed.ncbi.nlm.nih.gov/40974259/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40974259","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40974259/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40974259","source_url":"https://pubmed.ncbi.nlm.nih.gov/40974259/","doi":"10.1111/add.70187","pmid":"40974259","publication_date":"2025-09-20","importer_version":"2.1.3","text_redistributed":false}},{"id":389,"title":"A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder.","authors":"Brett J, Lea T, Knock E, Albert S, Acheson L, Siefried KJ, Job S","journal":"Addiction (Abingdon, England)","publication_date":"2025-12-22","publication_year":2025,"doi":"10.1111/add.70284","pubmed_id":"41424164","openalex_id":"https://openalex.org/W7116780285","source_url":"https://pubmed.ncbi.nlm.nih.gov/41424164/","substance_tags":"psilocybin","topic_tags":"Spirituality","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:54","bibtex":null,"source_record_id":"PMID:41424164","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41424164/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41424164","source_url":"https://pubmed.ncbi.nlm.nih.gov/41424164/","doi":"10.1111/add.70284","pmid":"41424164","publication_date":"2025-12-22","importer_version":"2.1.3","text_redistributed":false}},{"id":209,"title":"Unlocking 'stuckness' and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems.","authors":"Catchlove SJ, Oliver K, Savic M, Arunogiri S","journal":"Addiction (Abingdon, England)","publication_date":"2026-03-30","publication_year":2026,"doi":"10.1111/add.70403","pubmed_id":"41906885","openalex_id":"https://openalex.org/W7143442364","source_url":"https://pubmed.ncbi.nlm.nih.gov/41906885/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Healthcare Workers","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:51","bibtex":null,"source_record_id":"PMID:41906885","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41906885/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41906885","source_url":"https://pubmed.ncbi.nlm.nih.gov/41906885/","doi":"10.1111/add.70403","pmid":"41906885","publication_date":"2026-03-30","importer_version":"2.1.3","text_redistributed":false}}],"total":14,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Addiction (Abingdon, England)","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}